Multiple Myeloma Research Foundation - MMRF
Stephanie Oestreich has a diverse work experience in the biotech and pharmaceutical industry. Stephanie most recently served as the Managing Director at the Multiple Myeloma Research Foundation. Prior to that, they held positions such as Chief Business Officer at Galecto, Inc., Head of Operations and Alliance Management at Mnemo Therapeutics, and consultant for various Biotech Startups. Stephanie also worked as a Venture Partner at RA Capital Management and held executive roles at Evotec, Roche, and Novartis. Stephanie Oestreich has a background in academic partnerships, marketing/sales, institutional business, and strategic alliances. Stephanie has also worked as a lecturer at the Medical University of Vienna.
Stephanie Oestreich has a diverse and extensive education history. Stephanie began their education journey in 1995 at Freie Universität Berlin, where they obtained a Master's degree in Biochemistry in 1999. Stephanie then continued their academic pursuits and enrolled in the same institution for their Doctor of Philosophy (PhD) degree in Biochemistry. Stephanie successfully completed their PhD in 2004.
In addition to their education at Freie Universität Berlin, Stephanie also attended Harvard Kennedy School from 2000 to 2002, where they obtained a Master's in Public Administration (MPA). This indicates that they have a strong background in both biochemistry and public administration.
To further enhance their skills and qualifications, Stephanie has also acquired additional certifications. In 1999, they obtained a Master's in Biochemistry from Freie Universität Berlin, and in 2004, they earned their PhD certification in Biochemistry from the same institution. Furthermore, in 2015, Stephanie completed a Postgraduate Certificate in Leadership Capabilities from Glasgow Caledonian University. More recently, in 2019, they successfully completed the Boardroom Ready Program offered by Women In Bio.
Overall, Stephanie Oestreich's education history showcases a commitment to both scientific research and leadership development.
This person is not in any offices
Multiple Myeloma Research Foundation - MMRF
We drive the development and delivery of next-generation therapies, leverage data to identify optimal and more personalized treatment approaches, and empower myeloma patients and the broader community with information and resources to extend their lives. Central to our mission is our commitment to advancing health equity so that all myeloma patients can benefit from the scientific and clinical advances we pursue. Since our inception, the MMRF has committed over $500 million for research, opened nearly 100 clinical trials, and helped bring 15+ FDA-approved therapies to market, which have tripled the life expectancy of myeloma patients.